{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:26:13Z","timestamp":1791523573529,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1078220"],"award-info":[{"award-number":["APP1078220"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1194467"],"award-info":[{"award-number":["APP1194467"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"CCA | Cancer Council Victoria","doi-asserted-by":"publisher","award":["APP1157737"],"award-info":[{"award-number":["APP1157737"]}],"id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022084","name":"Peter MacCallum Cancer Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100022084","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100022084","name":"Peter MacCallum Cancer Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100022084","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rosie Lew Peter MacCallum Cancer Foundation Postgraduate Award","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100000947","name":"Australian Cancer Research Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000947","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government Research Training Program Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Hippo tumor suppressor pathway controls transcription by regulating nuclear abundance of YAP and TAZ, which activate transcription with the TEAD1-TEAD4 DNA-binding proteins. Recently, several small-molecule inhibitors of YAP and TEADs have been reported, with some entering clinical trials for different cancers with Hippo pathway deregulation, most notably, mesothelioma. Using genome-wide CRISPR\/Cas9 screens we reveal that mutations in genes from the Hippo, MAPK, and JAK-STAT signaling pathways all modulate the response of mesothelioma cell lines to TEAD palmitoylation inhibitors. By exploring gene expression programs of mutant cells, we find that MAPK pathway hyperactivation confers resistance to TEAD inhibition by reinstating expression of a subset of YAP\/TAZ target genes. Consistent with this, combined inhibition of TEAD and the MAPK kinase MEK, synergistically blocks proliferation of multiple mesothelioma and lung cancer cell lines and more potently reduces the growth of patient-derived lung cancer xenografts in vivo. Collectively, we reveal mechanisms by which cells can overcome small-molecule inhibition of TEAD palmitoylation and potential strategies to enhance the anti-tumor activity of emerging Hippo pathway targeted therapies.<\/jats:p>","DOI":"10.1038\/s44319-024-00217-3","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T10:02:12Z","timestamp":1722852132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-214X","authenticated-orcid":false,"given":"Aishwarya","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0774-4223","authenticated-orcid":false,"given":"Varshini","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-4263","authenticated-orcid":false,"given":"Tracy T","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Chih","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3089-0871","authenticated-orcid":false,"given":"Niko","family":"Thio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rosenbluh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0435-6824","authenticated-orcid":false,"given":"Joseph HA","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7845-369X","authenticated-orcid":false,"given":"Kieran F","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"217_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-9170-9_3","volume":"1961","author":"EK Brinkman","year":"2019","unstructured":"Brinkman EK, van Steensel B (2019) Rapid quantitative evaluation of CRISPR genome editing by TIDE and TIDER. Methods Mol Biol 1961:29\u201344","journal-title":"Methods Mol Biol"},{"key":"217_CR2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Miladinovic SM, Cheng LY, Messner S, Ehrenberger T, Zanotelli V, Butscheid Y, Escher C et al (2015) Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteom 14:1400\u20131410","journal-title":"Mol Cell Proteom"},{"key":"217_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.chembiol.2018.11.010","volume":"26","author":"K Bum-Erdene","year":"2019","unstructured":"Bum-Erdene K, Zhou D, Gonzalez-Gutierrez G, Ghozayel MK, Si Y, Xu D, Shannon HE, Bailey BJ, Corson TW, Pollok KE et al (2019) Small-molecule covalent modification of conserved cysteine leads to allosteric inhibition of the TEADYap protein-protein interaction. Cell Chem Biol 26:378\u2013389.e313","journal-title":"Cell Chem Biol"},{"key":"217_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.trecan.2019.04.001","volume":"5","author":"PC Calses","year":"2019","unstructured":"Calses PC, Crawford JJ, Lill JR, Dey A (2019) Hippo pathway in cancer: aberrant regulation and therapeutic opportunities. Trends Cancer 5:297\u2013307","journal-title":"Trends Cancer"},{"key":"217_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nchembio.2036","volume":"12","author":"P Chan","year":"2016","unstructured":"Chan P, Han X, Zheng B, DeRan M, Yu J, Jarugumilli GK, Deng H, Pan D, Luo X, Wu X (2016) Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway. Nat Chem Biol 12:282\u2013289","journal-title":"Nat Chem Biol"},{"key":"217_CR6","doi-asserted-by":"publisher","unstructured":"Chapeau EA, Sansregret L, Galli GG, Chene P, Wartmann M, Mourikis TP, Jaaks P, Baltschukat S, Barbosa IAM, Bauer D et al (2024) Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. https:\/\/doi.org\/10.1038\/s43018-024-00754-9","DOI":"10.1038\/s43018-024-00754-9"},{"key":"217_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2001","unstructured":"Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593\u2013604","journal-title":"Cell"},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A et al (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147:759\u2013772","journal-title":"Cell"},{"key":"217_CR9","doi-asserted-by":"publisher","first-page":"dev167106","DOI":"10.1242\/dev.167106","volume":"146","author":"JR Davis","year":"2019","unstructured":"Davis JR, Tapon N (2019) Hippo signalling during development. Development 146:dev167106","journal-title":"Development"},{"key":"217_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","volume":"19","author":"A Dey","year":"2020","unstructured":"Dey A, Varelas X, Guan KL (2020) Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov 19:480\u2013494","journal-title":"Nat Rev Drug Discov"},{"key":"217_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R et al (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34:184\u2013191","journal-title":"Nat Biotechnol"},{"key":"217_CR12","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nbt.3026","volume":"32","author":"JG Doench","year":"2014","unstructured":"Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE (2014) Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32:1262\u20131267","journal-title":"Nat Biotechnol"},{"key":"217_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","volume":"2","author":"LA Garraway","year":"2012","unstructured":"Garraway LA, Janne PA (2012) Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov 2:214\u2013226","journal-title":"Cancer Discov"},{"key":"217_CR14","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/cmdc.202100153","volume":"16","author":"F Gibault","year":"2021","unstructured":"Gibault F, Sturbaut M, Coevoet M, Pugniere M, Burtscher A, Allemand F, Melnyk P, Hong W, Rubin BP, Pobbati AV et al (2021) Design, synthesis and evaluation of a series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ\/TEAD Complex. ChemMedChem 16:2823\u20132844","journal-title":"ChemMedChem"},{"key":"217_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1021823","volume":"12","author":"A Gridnev","year":"2022","unstructured":"Gridnev A, Maity S, Misra JR (2022) Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Front Oncol 12:1021823","journal-title":"Front Oncol"},{"key":"217_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47423-0","volume":"15","author":"F Haderk","year":"2024","unstructured":"Haderk F, Chou YT, Cech L, Fern\u00e1ndez-M\u00e9ndez C, Yu J, Olivas V, Meraz IM, Rabago DB, Kerr DL, Gomez C et al (2024) Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. Nat Commun 15:3741","journal-title":"Nat Commun"},{"key":"217_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dev.045500","volume":"138","author":"G Halder","year":"2011","unstructured":"Halder G, Johnson RL (2011) Hippo signaling: growth control and beyond. Development 138:9\u201322","journal-title":"Development"},{"key":"217_CR18","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao Y, Chun A, Cheung K, Rashidi B, Yang X (2008) Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283:5496\u20135509","journal-title":"J Biol Chem"},{"key":"217_CR19","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","volume":"163","author":"T Hart","year":"2015","unstructured":"Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S et al (2015) High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163:1515\u20131526","journal-title":"Cell"},{"key":"217_CR20","doi-asserted-by":"publisher","first-page":"a011288","DOI":"10.1101\/cshperspect.a011288","volume":"4","author":"KF Harvey","year":"2012","unstructured":"Harvey KF, Hariharan IK (2012) The Hippo pathway. Cold Spring Harb Perspect Biol 4:a011288","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"217_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13:246\u2013257","journal-title":"Nat Rev Cancer"},{"key":"217_CR22","doi-asserted-by":"publisher","first-page":"e67312","DOI":"10.7554\/eLife.67312","volume":"10","author":"L He","year":"2021","unstructured":"He L, Pratt H, Gao M, Wei F, Weng Z, Struhl K (2021) YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. Elife 10:e67312","journal-title":"Elife"},{"issue":"Pt 2","key":"217_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J 334(Pt 2):297\u2013314","journal-title":"Biochem J"},{"key":"217_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cub.2012.02.050","volume":"22","author":"H Herranz","year":"2012","unstructured":"Herranz H, Hong X, Cohen SM (2012) Mutual repression by bantam miRNA and Capicua links the EGFR\/MAPK and Hippo pathways in growth control. Curr Biol 22:651\u2013657","journal-title":"Curr Biol"},{"key":"217_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107809","volume":"31","author":"JK Holden","year":"2020","unstructured":"Holden JK, Crawford JJ, Noland CL, Schmidt S, Zbieg JR, Lacap JA, Zang R, Miller GM, Zhang Y, Beroza P et al (2020) Small molecule dysregulation of TEAD lipidation induces a dominant-negative inhibition of Hippo pathway signaling. Cell Rep. 31:107809","journal-title":"Cell Rep."},{"key":"217_CR26","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1110955","volume":"309","author":"JH Hong","year":"2005","unstructured":"Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA et al (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074\u20131078","journal-title":"Science"},{"key":"217_CR27","doi-asserted-by":"publisher","first-page":"e80210","DOI":"10.7554\/eLife.80210","volume":"11","author":"L Hu","year":"2022","unstructured":"Hu L, Sun Y, Liu S, Erb H, Singh A, Mao J, Luo X, Wu X (2022) Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode. Elife 11:e80210","journal-title":"Elife"},{"key":"217_CR28","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"A Ianevski","year":"2017","unstructured":"Ianevski A, He L, Aittokallio T, Tang J (2017) SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics 33:2413\u20132415","journal-title":"Bioinformatics"},{"key":"217_CR29","first-page":"4399","volume":"10","author":"A Kaneda","year":"2020","unstructured":"Kaneda A, Seike T, Danjo T, Nakajima T, Otsubo N, Yamaguchi D, Tsuji Y, Hamaguchi K, Yasunaga M, Nishiya Y et al (2020) The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma. Am J Cancer Res 10:4399\u20134415","journal-title":"Am J Cancer Res"},{"key":"217_CR30","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddl136","volume":"15","author":"M Kawamura-Saito","year":"2006","unstructured":"Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H et al (2006) Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19) (q35;q13) translocation. Hum Mol Genet 15:2125\u20132137","journal-title":"Hum Mol Genet"},{"key":"217_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trecan.2020.08.010","volume":"7","author":"JW Kim","year":"2021","unstructured":"Kim JW, Ponce RK, Okimoto RA (2021) Capicua in human cancer. Trends Cancer 7:77\u201386","journal-title":"Trends Cancer"},{"key":"217_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.15252\/embj.201592081","volume":"35","author":"MH Kim","year":"2016","unstructured":"Kim MH, Kim J, Hong H, Lee SH, Lee JK, Jung E, Kim J (2016) Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP\/TAZ activation. EMBO J 35:462\u2013478","journal-title":"EMBO J"},{"key":"217_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"JH Koo","year":"2018","unstructured":"Koo JH, Guan KL (2018) Interplay between YAP\/TAZ and metabolism. Cell Metab 28:196\u2013206","journal-title":"Cell Metab"},{"key":"217_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.331546.119","volume":"34","author":"JH Koo","year":"2020","unstructured":"Koo JH, Plouffe SW, Meng Z, Lee DH, Yang D, Lim DS, Wang CY, Guan KL (2020) Induction of AP-1 by YAP\/TAZ contributes to cell proliferation and organ growth. Genes Dev 34:72\u201386","journal-title":"Genes Dev"},{"key":"217_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.devcel.2013.04.021","volume":"25","author":"LM Koontz","year":"2013","unstructured":"Koontz LM, Liu-Chittenden Y, Yin F, Zheng Y, Yu J, Huang B, Chen Q, Wu S, Pan D (2013) The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev Cell 25:388\u2013401","journal-title":"Dev Cell"},{"key":"217_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.trecan.2020.04.004","volume":"6","author":"A Kulkarni","year":"2020","unstructured":"Kulkarni A, Chang MT, Vissers JHA, Dey A, Harvey KF (2020) The Hippo pathway as a driver of select human cancers. Trends Cancer 6:781\u2013796","journal-title":"Trends Cancer"},{"key":"217_CR37","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/brain\/awac342","volume":"146","author":"L Laraba","year":"2023","unstructured":"Laraba L, Hillson L, de Guibert JG, Hewitt A, Jaques MR, Tang TT, Post L, Ercolano E, Rai G, Yang SM et al (2023) Inhibition of YAP\/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. Brain 146:1697\u20131713","journal-title":"Brain"},{"key":"217_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/path.4894","volume":"242","author":"VG LeBlanc","year":"2017","unstructured":"LeBlanc VG, Firme M, Song J, Chan SY, Lee MH, Yip S, Chittaranjan S, Marra MA (2017) Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade. J Pathol 242:206\u2013220","journal-title":"J Pathol"},{"key":"217_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.stem.2020.03.002","volume":"26","author":"Q Li","year":"2020","unstructured":"Li Q, Sun Y, Jarugumilli GK, Liu S, Dang K, Cotton JL, Xiol J, Chan PY, DeRan M, Ma L et al (2020) Lats1\/2 sustain intestinal stem cells and Wnt activation through TEAD-dependent and independent transcription. Cell Stem Cell 26:675\u2013692.e678","journal-title":"Cell Stem Cell"},{"key":"217_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li W, Koster J, Xu H, Chen CH, Xiao T, Liu JS, Brown M, Liu XS (2015) Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol 16:281","journal-title":"Genome Biol"},{"key":"217_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, Irizarry RA, Liu JS, Brown M, Liu XS (2014) MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol 15:554","journal-title":"Genome Biol"},{"key":"217_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27:1739\u20131740","journal-title":"Bioinformatics"},{"key":"217_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ng.3218","volume":"47","author":"L Lin","year":"2015","unstructured":"Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E, Asthana S, Neel D, Yan JJ, Lu X (2015) The Hippo effector YAP promotes resistance to RAF-and MEK-targeted cancer therapies. Nat Genet 47:250\u2013256","journal-title":"Nat Genet"},{"key":"217_CR44","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1093\/nar\/gkv412","volume":"43","author":"R Liu","year":"2015","unstructured":"Liu R, Holik AZ, Su S, Jansz N, Chen K, Leong HS, Blewitt ME, Asselin-Labat ML, Smyth GK, Ritchie ME (2015) Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res 43:e97","journal-title":"Nucleic Acids Res"},{"key":"217_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.celrep.2015.12.104","volume":"14","author":"X Liu","year":"2016","unstructured":"Liu X, Li H, Rajurkar M, Li Q, Cotton JL, Ou J, Zhu LJ, Goel HL, Mercurio AM, Park JS et al (2016) Tead and AP1 Coordinate Transcription and Motility. Cell Rep 14:1169\u20131180","journal-title":"Cell Rep"},{"key":"217_CR46","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1016\/j.apsb.2021.04.015","volume":"11","author":"T Lu","year":"2021","unstructured":"Lu T, Li Y, Lu W, Spitters T, Fang X, Wang J, Cai S, Gao J, Zhou Y, Duan Z et al (2021) Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3. Acta Pharm Sin B 11:3206\u20133219","journal-title":"Acta Pharm Sin B"},{"key":"217_CR47","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1021\/acs.jmedchem.2c01548","volume":"66","author":"W Lu","year":"2023","unstructured":"Lu W, Fan M, Ji W, Tse J, You I, Ficarro SB, Tavares I, Che J, Kim AY, Zhu X et al (2023) Structure-based design of Y-shaped covalent TEAD inhibitors. J Med Chem 66:4617\u20134632","journal-title":"J Med Chem"},{"key":"217_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111767","volume":"184","author":"W Lu","year":"2019","unstructured":"Lu W, Wang J, Li Y, Tao H, Xiong H, Lian F, Gao J, Ma H, Lu T, Zhang D et al (2019) Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors. Eur J Med Chem 184:111767","journal-title":"Eur J Med Chem"},{"key":"217_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1158\/1078-0432.CCR-13-0780","volume":"20","author":"A Luscan","year":"2014","unstructured":"Luscan A, Shackleford G, Masliah-Planchon J, Laurendeau I, Ortonne N, Varin J, Lallemand F, Leroy K, Dumaine V, Hivelin M et al (2014) The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis. Clin Cancer Res 20:358\u2013371","journal-title":"Clin Cancer Res"},{"key":"217_CR50","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.devcel.2024.04.006","volume":"59","author":"SA Manning","year":"2024","unstructured":"Manning SA, Kroeger B, Deng Q, Brooks E, Fonseka Y, Hinde E, Harvey KF (2024) The Drosophila Hippo pathway transcription factor Scalloped and its co-factors alter each other\u2019s chromatin binding dynamics and transcription in vivo. Dev Cell 59:1640\u20131654.e5","journal-title":"Dev Cell"},{"key":"217_CR51","doi-asserted-by":"publisher","first-page":"dev179069","DOI":"10.1242\/dev.179069","volume":"147","author":"SA Manning","year":"2020","unstructured":"Manning SA, Kroeger B, Harvey KF (2020) The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway. Development 147:dev179069","journal-title":"Development"},{"key":"217_CR52","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/JTO.0000000000000493","volume":"10","author":"A Miyanaga","year":"2015","unstructured":"Miyanaga A, Masuda M, Tsuta K, Kawasaki K, Nakamura Y, Sakuma T, Asamura H, Gemma A, Yamada T (2015) Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol 10:844\u2013851","journal-title":"J Thorac Oncol"},{"key":"217_CR53","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","volume":"71","author":"H Murakami","year":"2011","unstructured":"Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y et al (2011) LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res 71:873\u2013883","journal-title":"Cancer Res"},{"key":"217_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.str.2015.11.005","volume":"24","author":"CL Noland","year":"2016","unstructured":"Noland CL, Gierke S, Schnier PD, Murray J, Sandoval WN, Sagolla M, Dey A, Hannoush RN, Fairbrother WJ, Cunningham CN (2016) Palmitoylation of TEAD transcription factors is required for their stability and function in Hippo pathway signaling. Structure 24:179\u2013186","journal-title":"Structure"},{"key":"217_CR55","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1242\/dev.139857","volume":"143","author":"N Obier","year":"2016","unstructured":"Obier N, Cauchy P, Assi SA, Gilmour J, Lie ALM, Lichtinger M, Hoogenkamp M, Noailles L, Cockerill PN, Lacaud G et al (2016) Cooperative binding of AP-1 and TEAD4 modulates the balance between vascular smooth muscle and hemogenic cell fate. Development 143:4324\u20134340","journal-title":"Development"},{"key":"217_CR56","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1158\/0008-5472.CAN-20-0907","volume":"80","author":"J Park","year":"2020","unstructured":"Park J, Eisenbarth D, Choi W, Kim H, Choi C, Lee D, Lim DS (2020) YAP and AP-1 cooperate to initiate pancreatic cancer development from ductal cells in mice. Cancer Res 80:4768\u20134779","journal-title":"Cancer Res"},{"key":"217_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.devcel.2017.08.013","volume":"42","author":"J Pascual","year":"2017","unstructured":"Pascual J, Jacobs J, Sansores-Garcia L, Natarajan M, Zeitlinger J, Aerts S, Halder G, Hamaratoglu F (2017) Hippo reprograms the transcriptional response to Ras signaling. Dev Cell 42:667\u2013680.e664","journal-title":"Dev Cell"},{"key":"217_CR58","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.CD-20-0706","volume":"11","author":"TH Pham","year":"2021","unstructured":"Pham TH, Hagenbeek TJ, Lee HJ, Li J, Rose CM, Lin E, Yu M, Martin SE, Piskol R, Lacap JA et al (2021) Machine-learning and chemicogenomics approach defines and predicts cross-talk of Hippo and MAPK pathways. Cancer Discov 11:778\u2013793","journal-title":"Cancer Discov"},{"key":"217_CR59","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.str.2015.09.009","volume":"23","author":"AV Pobbati","year":"2015","unstructured":"Pobbati AV, Han X, Hung AW, Weiguang S, Huda N, Chen GY, Kang C, Chia CS, Luo X, Hong W et al (2015) Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy. Structure 23:2076\u20132086","journal-title":"Structure"},{"key":"217_CR60","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tibs.2022.12.005","volume":"48","author":"AV Pobbati","year":"2023","unstructured":"Pobbati AV, Kumar R, Rubin BP, Hong W (2023) Therapeutic targeting of TEAD transcription factors in cancer. Trends Biochem Sci 48:450\u2013462","journal-title":"Trends Biochem Sci"},{"key":"217_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290\u2013301","journal-title":"Nat Rev Cancer"},{"key":"217_CR62","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings JS, Rosler KM, Harrison DA (2004) The JAK\/STAT signaling pathway. J Cell Sci 117:1281\u20131283","journal-title":"J Cell Sci"},{"key":"217_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.devcel.2013.01.020","volume":"24","author":"BV Reddy","year":"2013","unstructured":"Reddy BV, Irvine KD (2013) Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell 24:459\u2013471","journal-title":"Dev Cell"},{"key":"217_CR64","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/ml300049d","volume":"3","author":"KD Rice","year":"2012","unstructured":"Rice KD, Aay N, Anand NK, Blazey CM, Bowles OJ, Bussenius J, Costanzo S, Curtis JK, Defina SC, Dubenko L et al (2012) Novel carboxamide-based allosteric MEK inhibitors: discovery and optimization efforts toward XL518 (GDC-0973). ACS Med Chem Lett 3:416\u2013421","journal-title":"ACS Med Chem Lett"},{"key":"217_CR65","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47","journal-title":"Nucleic Acids Res"},{"key":"217_CR66","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11:783\u2013784","journal-title":"Nat Methods"},{"key":"217_CR67","first-page":"1227","volume":"55","author":"Y Sekido","year":"1995","unstructured":"Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227\u20131231","journal-title":"Cancer Res"},{"key":"217_CR68","doi-asserted-by":"publisher","first-page":"e1005465","DOI":"10.1371\/journal.pgen.1005465","volume":"11","author":"C Stein","year":"2015","unstructured":"Stein C, Bardet AF, Roma G, Bergling S, Clay I, Ruchti A, Agarinis C, Schmelzle T, Bouwmeester T, Schubeler D et al (2015) YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet 11:e1005465","journal-title":"PLoS Genet"},{"key":"217_CR69","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"217_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34559-0","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Hu L, Tao Z, Jarugumilli GK, Erb H, Singh A, Li Q, Cotton JL, Greninger P, Egan RK et al (2022) Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells. Nat Commun 13:6744","journal-title":"Nat Commun"},{"key":"217_CR71","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1535-7163.MCT-20-0717","volume":"20","author":"TT Tang","year":"2021","unstructured":"Tang TT, Konradi AW, Feng Y, Peng X, Ma M, Li J, Yu FX, Guan KL, Post L (2021) Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. Mol Cancer Ther 20:986\u2013998","journal-title":"Mol Cancer Ther"},{"key":"217_CR72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0092-8674(02)00824-3","volume":"110","author":"N Tapon","year":"2002","unstructured":"Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA, Hariharan IK (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110:467\u2013478","journal-title":"Cell"},{"key":"217_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02898-w","volume":"24","author":"NK Tuano","year":"2023","unstructured":"Tuano NK, Beesley J, Manning M, Shi W, Perlaza-Jimenez L, Malaver-Ortega LF, Paynter JM, Black D, Civitarese A, McCue K et al (2023) CRISPR screens identify gene targets at breast cancer risk loci. Genome Biol 24:59","journal-title":"Genome Biol"},{"key":"217_CR74","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731\u2013740","journal-title":"Nat Methods"},{"key":"217_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-61779-080-5_8","volume":"731","author":"CC Uphoff","year":"2011","unstructured":"Uphoff CC, Drexler HG (2011) Detecting mycoplasma contamination in cell cultures by polymerase chain reaction. Methods Mol Biol 731:93\u2013103","journal-title":"Methods Mol Biol"},{"key":"217_CR76","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","volume":"10","author":"X Varelas","year":"2008","unstructured":"Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10:837\u2013848","journal-title":"Nat Cell Biol"},{"key":"217_CR77","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1101\/gad.192955.112","volume":"26","author":"W Wang","year":"2012","unstructured":"Wang W, Huang J, Wang X, Yuan J, Li X, Feng L, Park JI, Chen J (2012) PTPN14 is required for the density-dependent control of YAP1. Genes Dev 26:1959\u20131971","journal-title":"Genes Dev"},{"key":"217_CR78","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.celrep.2018.10.001","volume":"25","author":"Y Wang","year":"2018","unstructured":"Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH et al (2018) Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Rep 25:1304\u20131317.e1305","journal-title":"Cell Rep"},{"key":"217_CR79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O\u2019Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599\u2013608","journal-title":"Cell"},{"key":"217_CR80","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, Rosato A, Bicciato S, Cordenonsi M, Piccolo S (2015) Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol 17:1218\u20131227","journal-title":"Nat Cell Biol"},{"key":"217_CR81","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41388-020-1362-9","volume":"39","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yang L, Szeto P, Abali GK, Zhang Y, Kulkarni A, Amarasinghe K, Li J, Vergara IA, Molania R et al (2020) The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis. Oncogene 39:5267\u20135281","journal-title":"Oncogene"},{"key":"217_CR82","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM et al (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962\u20131971","journal-title":"Genes Dev"},{"key":"217_CR83","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","volume":"50","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Pan D (2019) The Hippo signaling pathway in development and disease. Dev Cell 50:264\u2013282","journal-title":"Dev Cell"},{"key":"217_CR84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccell.2020.02.003","volume":"37","author":"ZY Zheng","year":"2020","unstructured":"Zheng ZY, Anurag M, Lei JT, Cao J, Singh P, Peng J, Kennedy H, Nguyen NC, Chen Y, Lavere P et al (2020) Neurofibromin is an estrogen receptor-alpha transcriptional co-repressor in breast cancer. Cancer Cell 37:387\u2013402.e387","journal-title":"Cancer Cell"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-024-00217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-024-00217-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-024-00217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:03:18Z","timestamp":1785855798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-024-00217-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,10]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1038\/s44319-024-00217-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.08.16.553491","asserted-by":"object"}]},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TT Tang and L Post report employment with Vivace Therapeutics and have equity interest in Vivace Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"14"}}